Healthcare

Botanix Pharmaceuticals (ASX:BOT) has moved beyond its clinical development phase and is now focused on building a commercialBusinessaround Sofdra (sofpironium), its FDA-approved topical treatment for primary axillary hyperhidrosis. The condition involves excessive underarm sweating and represents an area where prescription treatmentOptionshave historically been limited.

Trajan Group Holdings (ASX:TRJ) is an Australian-headquartered developer and manufacturer of analytical and life-sciences products used in laboratories globally. Its products support applications across areas including human health testing, food analysis and environmental monitoring.

Immutep Ltd (ASX:IMM) is a clinical-stage biotechnology company developing cancer immunotherapies based on the LAG-3 immune-control pathway. Its lead candidate, eftilagimod alfa (efti), is being evaluated in combination with established cancer treatments across several tumour types.

TELIX Pharmaceuticals Ltd (ASX: TLX) is back in focus after its shares gained 3.67% to AUD 15.83 on 2 September 2026. The company had a market capitalisation of AUD 5380mn and a one-year share-price performance of 10.62%. The latest move comes as investors assess …

Micro-X Ltd (ASX: MX1) is drawing fresh market attention after its shares rose 4.00% to AUD 0.026 on 2 September 2026. The company’sMarket Capitalisationstood at AUD 19.56mn, while its one-year share performance was -66.67%. The latest move puts the stock back in focus as …

Beamtree Holdings Ltd (ASX:BMT) rose 4.76% to AUD 0.11, putting the healthcare technology stock back in focus after a 50% one-year decline in the supplied market data. The company is building a healthcare data and AI platform around coding, quality, benchmarking and clinical information, …

4DMEDICAL Ltd (ASX:4DX) gained 3.80% to AUD 3.55, keeping one of the market’s standout healthcare technology stocks in focus after a 361.04% one-year gain in the supplied data. The company is continuing to expand its advanced respiratory imaging platform, with CT:VQ approvals, customer adoption, …